GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 million pounds ($57 million) fund backing early drug research.
Read more.
Source: Reuters
Filed Under: Drug Discovery
GSK, Astra, J&J, Link with Universities in New Drug Research Fund
Filed Under: Drug Discovery
